Long-term survival of corneal allografts is dependent on intact CD1d-reactive NKT cells

被引:89
作者
Sonoda, KH
Taniguchi, M
Stein-Streilein, J
机构
[1] Harvard Univ, Sch Med, Schepens Eye Res Inst, Boston, MA 02114 USA
[2] Chiba Univ, Core Res & Evolut Sci & Technol Project, Chiba, Japan
[3] Chiba Univ, Dept Mol Immunol, Chiba, Japan
[4] Brigham & Womens Hosp, Dept Med, Div Pulm & Crit Care, Boston, MA 02115 USA
[5] Kyushu Univ, Sch Med, Dept Ophthalmol, Fukuoka 812, Japan
关键词
D O I
10.4049/jimmunol.168.4.2028
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
BALB/c mice that tolerate the allogeneic grafts develop allogeneic-specific anterior chamber-associated immune deviation. Because CD1d-reactive NKT cells are essential for anterior chamber-associated immune deviation, we postulated that the survival of C57BL/6 (B6) cornea graft in BALB/c mice was also dependent on CD Id-reactive NKT cells. The B6 corneal graft rejection rate in BALB/c vs Jalpha281 knockout (KO) mice, which lack NKT cells, was measured. While there were no difference in the early phase of rejection, the survival rates at 12 wk after grafting for BALB/c and Jalpha281 KO mice were 50 and 0%, respectively. Because anti-CD1d mAb abrogated the corneal graft survival in the wild-type mice we concluded that CD1d-reactive NKT cells were essential for graft survival. Moreover, allospecific T regulatory (Tr) cells correlated with acceptance of B6 grafts in BALB/c mice, and the adoptive transfer of these allospecific Tr cells to Ja281 KO mice allowed a 50% survival rate of B6 cornea grafts. In conclusion, CD1d-reactive NKT cells are required for induction of allospecific Tr cells and are essential for survival of corneal allografts. Mechanisms that contribute to cornea graft acceptance may lead to new therapies for improvement in graft survival in high-risk corneas and other transplanted tissues and grafts.
引用
收藏
页码:2028 / 2034
页数:7
相关论文
共 52 条
[1]
Azuma M, 2000, EUR J IMMUNOL, V30, P2138
[2]
Behar SM, 1999, J IMMUNOL, V162, P161
[3]
Mouse CD1-specific NK1 T cells: Development, specificity, and function [J].
Bendelac, A ;
Rivera, MN ;
Park, SH ;
Roark, JH .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :535-562
[4]
POSITIVE SELECTION OF MOUSE NK1(+) T-CELLS BY CD1-EXPRESSING CORTICAL THYMOCYTES [J].
BENDELAC, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (06) :2091-2096
[5]
CD1 RECOGNITION BY MOUSE NK1(+) T-LYMPHOCYTES [J].
BENDELAC, A ;
LANTZ, O ;
QUIMBY, ME ;
YEWDELL, JW ;
BENNINK, JR ;
BRUTKIEWICZ, RR .
SCIENCE, 1995, 268 (5212) :863-865
[6]
In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers [J].
Benlagha, K ;
Weiss, A ;
Beavis, A ;
Teyton, L ;
Bendelac, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (11) :1895-1903
[7]
THE PRESENCE OF DONOR-DERIVED CLASS-II-POSITIVE CELLS ABOLISHES IMMUNE PRIVILEGE IN THE ANTERIOR-CHAMBER OF THE EYE [J].
BENSON, JL ;
NIEDERKORN, JY .
TRANSPLANTATION, 1991, 51 (04) :834-838
[8]
Brossay L, 1998, J IMMUNOL, V160, P3681
[9]
Impaired NK1(+) T cell development and early IL-4 production in CD1-deficient mice [J].
Chen, YH ;
Chiu, NM ;
Mandal, M ;
Wang, N ;
Wang, CR .
IMMUNITY, 1997, 6 (04) :459-467
[10]
Requirement for V(alpha)14 NKT cells in IL-12-mediated rejection of tumors [J].
Cui, JQ ;
Shin, T ;
Kawano, T ;
Sato, H ;
Kondo, E ;
Toura, I ;
Kaneko, Y ;
Koseki, H ;
Kanno, M ;
Taniguchi, M .
SCIENCE, 1997, 278 (5343) :1623-1626